This funding opportunity, provided by the National Institutes of Health (NIH), supports the advancement of non-hormonal contraceptive and reproductive health product development. The Chemical Synthesis and Optimization Facility offers state-of-the-art preclinical services, including protein generation, X-ray crystallography, high throughput screening, structure activity relationship studies, hit-to-lead generation, and drug metabolism. The long-term goal is to facilitate the development of preclinical candidates for Investigational Device Exemption (IDE) or Investigational New Drug (IND) studies, leading to safe therapeutic options in contraception and reproductive health.
This funding opportunity, provided by the National Institutes of Health (NIH), supports the advancement of non-hormonal contraceptive and reproductive health product development. The Chemical Synthesis and Optimization Facility offers state-of-the-art preclinical services, including protein generation, X-ray crystallography, high throughput screening, structure activity relationship studies, hit-to-lead generation, and drug metabolism. The long-term goal is to facilitate the development of preclinical candidates for Investigational Device Exemption (IDE) or Investigational New Drug (IND) studies, leading to safe therapeutic options in contraception and reproductive health.